Episode Details

A new Delaware bill aims to revolutionize Alzheimer’s and dementia care by mandating insurance coverage for critical biomarker tests—giving patients earlier, more accurate diagnoses. Advocates, including the Alzheimer’s Association, stress that timely testing empowers families to plan and manage care effectively. Personal stories, like Glen Gray’s two-year struggle to diagnose his wife’s early-onset dementia, highlight the human cost of delays. The bill, already approved by the Senate, ensures tests are only covered when medically necessary and is poised to pass the House—offering hope as the state’s population ages and Alzheimer’s remains the seventh leading cause of death in the U.S.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/d9cab1478dbdbb7e